Research Article
Hypofibrinolytic State in Subjects with Type 2 Diabetes Mellitus Aggravated by the Metabolic Syndrome before Clinical Manifestations of Atherothrombotic Disease
Table 1
Comparison of clinical and biochemical characteristics between diabetic subjects with the Metabolic Syndrome and the reference group.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Continuous variables with normal distribution are expressed as mean ± standard deviation. Continuous variables with nonnormal distribution are expressed as median (interquartile range). Categorical variables are expressed as total number and percentages. MetS: the Metabolic Syndrome; FPG: fasting plasma glucose; HbA1c: glycosylated hemoglobin; BMI: body mass index; WC: waist circumference; HDL-c: high-density lipoprotein cholesterol; PAI-1: plasminogen activator inhibitor type-1; FH of AT: familial history of atherothrombotic disease. |